Sterility Testing of In Vitro Diagnostic Reagents: Standards, Methods, and Quality Control

Sterility testing of in vitro diagnostic (IVD) reagents is a critical microbiological quality control procedure that verifies products labeled as sterile are free from viable bacteria, yeasts, and molds. This technical article explains the applicable standards, representative sample types, membrane filtration and direct inoculation methods, method suitability validation, and typical applications in IVD manufacturing and regulatory submission.

Technical Overview

Sterility testing is a destructive microbiological assay performed on in vitro diagnostic reagents that are declared or labeled as sterile, including molecular diagnostics reagents, blood typing reagents, sterile buffers and diluents, culture media, calibrators, and quality control materials. The purpose of the test is to demonstrate, within the statistical limits of the sampling plan, that a batch of product contains no viable microorganisms. For IVD manufacturers, sterility testing supports batch release, product registration, process validation of aseptic filling or sterile filtration, and ongoing stability programs.

The test is typically performed in accordance with recognized pharmacopoeial and international standards, including:

• Chinese Pharmacopoeia (ChP), General Chapter 1101, Sterility Test
• ISO 11737-1, Sterilization of health care products – Microbiological methods – Part 1: Determination of a population of microorganisms on products
• GB/T 19973.1, the Chinese national standard adopted from ISO 11737-1
• USP <71> and Ph. Eur. 2.6.1, harmonized pharmacopoeial sterility test chapters
• ISO 14644-1 for the classified cleanroom environment in which the test is conducted

Testing must be carried out under aseptic conditions, normally in an ISO Class 5 (Grade A) laminar airflow cabinet or restricted access barrier system/isolator located within an ISO Class 7 (Grade B) background environment, with concurrent environmental monitoring to confirm test validity.

Testing Samples

Sterile Liquid Reagents

This category includes buffers, wash solutions, sample diluents, substrate solutions, conjugates, and PCR master mixes that are filled aseptically or sterilized by 0.22 µm filtration. Liquid products are the most straightforward matrix for sterility testing and are well suited to the membrane filtration method.

Lyophilized and Powder Reagents

Freeze-dried reagent beads, lyophilized calibrators, and powdered culture media must be reconstituted with sterile diluent before testing. The reconstitution volume, solvent type, and mixing procedure must be defined in the test protocol so that the entire active content of the unit is examined.

Culture Media and Microbiology Reagents

Liquid and solid culture media, enrichment broths, and suspending fluids supplied as sterile IVD products require sterility verification, typically as part of each manufacturing batch release and as a growth-promotion prerequisite before use in microbiological laboratories.

Calibrators, Controls, and Ancillary Components

Sterile calibrators, control materials, anticoagulant solutions, and kit components supplied in multi-dose containers should be sampled from the beginning, middle, and end of the fill to provide representative coverage of the batch.

Testing Items

A complete sterility testing program for IVD reagents generally includes the following elements:

• Sterility test using two culture media: fluid thioglycollate medium (FTM) incubated at 30–35 °C for aerobic and anaerobic bacteria, and soybean–casein digest medium (SCDM/TSB) incubated at 20–25 °C for aerobic bacteria and fungi, both observed over a 14-day incubation period
• Growth promotion testing of each lot of culture medium using compendial reference strains
• Method suitability validation, also known as the bacteriostasis and fungistasis test, to demonstrate that the reagent matrix does not inhibit microbial growth under the chosen test conditions
• Positive controls using low-level inocula (fewer than 100 CFU) of standard strains
• Negative controls, including diluent and rinse fluid controls, to detect extraneous contamination
• Environmental monitoring of the testing area, including viable air and surface samples, as a condition for test validity

Testing Methods

Membrane Filtration Method

Membrane filtration is the preferred technique whenever the product is a filterable liquid. A defined volume of the reagent is passed through a sterile membrane filter with a nominal pore size of 0.45 µm, which retains any microorganisms present. The membrane is then rinsed with sterile rinse fluid, such as 0.1% peptone water, often supplemented with neutralizers like polysorbate 20/80 and lecithin, to remove residual antimicrobial or preservative substances. After the final rinse, the membrane is transferred aseptically into FTM and SCDM, or the media are introduced into the filtration canister, and the tubes are incubated for 14 days with observations on day 3 (or 7) and at the end of incubation.

Direct Inoculation Method

Direct inoculation is applied to products that cannot be filtered, such as viscous, oily, or high-protein formulations. The specified quantity of reagent is transferred directly into the two culture media, and the volume of product should generally not exceed 10% of the medium volume unless suitability has been demonstrated, so that the growth-promoting properties of the medium are not diluted. Incubation conditions and the observation schedule are identical to the membrane filtration method.

Method Suitability Validation

Before routine testing, each product formulation must be validated for method suitability. Low inocula of the six compendial strains—

Staphylococcus aureus

Pseudomonas aeruginosa

Bacillus subtilis

Clostridium sporogenes

Candida albicans

Aspergillus brasiliensis

Applications

Sterility testing of IVD reagents is applied across the product lifecycle and regulatory landscape:

• Batch release testing of finished sterile reagents prior to distribution, in compliance with good manufacturing practice requirements
• Technical documentation for product registration and market approval submissions, where sterility data demonstrate conformity to safety requirements
• Validation of aseptic filling processes and 0.22 µm sterile filtration during process qualification
• Long-term and accelerated stability studies to confirm that sterility is maintained through the claimed shelf life
• Investigation of sterility test failures, including identification of isolates and assessment of laboratory versus manufacturing origin
• Qualification of multi-dose containers and preservative-effectiveness supporting studies for products that allow repeated entries
• Vendor and incoming material control, where sterile raw materials and components are verified before use in kit assembly

FAQ

Do all IVD reagents require sterility testing?

No. Sterility testing applies to products that are labeled or intended to be sterile. Reagents with preservative systems and non-sterile intended use are instead evaluated through bioburden determination, antimicrobial effectiveness testing, or microbial limits testing as appropriate to the product's design and intended use.

How is the choice between membrane filtration and direct inoculation made?

Membrane filtration is preferred for aqueous, filterable liquids because it allows large volumes to be examined and removes inhibitory substances through rinsing. Direct inoculation is reserved for matrices that cannot be filtered or that contain the active ingredient in a form that would be retained by the membrane.

How long does a sterility test take?

The standard incubation period is 14 days for both media, with intermediate readings. Including sample preparation, method setup, and final observation, a routine sterility test typically requires two to three weeks from start to reporting.

What happens if turbidity or growth is observed?

Growth in the test indicates the possible presence of microorganisms, and the result is initially treated as a test failure. The microorganism is identified, and the investigation determines whether the contamination originates from the product, the test environment, or laboratory error. Re-testing or additional sampling is only permissible when laboratory error can be clearly documented, in accordance with the applicable pharmacopoeial and regulatory guidance.

Can rapid microbiological methods replace the classical test?

Validated rapid sterility methods based on growth detection, automated incubation and reading, or cellular activity markers may be used as alternatives. Such methods must be validated for specificity, limit of detection, robustness, and equivalence to the compendial method, in line with guidance such as USP <1223> and Ph. Eur. 5.1.6 on alternative microbiological methods.

How many samples should be tested from each batch?

The number of units sampled depends on the batch size and the applicable monograph or standard. The sampling plan must be statistically justified and documented so that the tested units are representative of the entire manufacturing batch, including considerations for fill sequence and container-closure configuration.